I am excited to release the 2009 OnBioVC Year-in-Review Trend Analysis study. It is available for free download [HERE]; the study now features OnBioIPO and OnBioM&A data too!

Bioscience venture capitalists invested $6.28 billion in 352 deals in 2009. Venture investments in 2009 represented a 3 percent increase in dollars and a 5 percent increase in deal volume from 2008. Investments in the fourth quarter of 2009 totaled $1.47 billion in 85 deals, a 13 percent decline in dollars and a 12 percent decrease in deals from the third quarter of 2009 when $1.66 billion went into 95 deals.

In a period where overall venture investments have declined to the lowest levels in more than a decade, bioscience investment activity in 2009 was less than 5 percent shy of the average annual investment totals for the last ten years. Given the challenging economic environment there was evidence of an insulated focus on continued investment in biomedical innovation. The 2009 OnBioVC Year-in-Review Trend Analysis presents details of the resilient 2009 bioscience venture capital market in addition to particulars on the thawing public markets and, information about twelve months of hyper-active biopharma M&A transactions.

Please feel free to share this document with peers and colleagues and do not forget to sign-up to receive OnBioVC, M&A and IPO updates at OnBioVC.com.

__________________________________________________________________________________

Sign up [HERE] for FREE Subscriptions to ‘Pharmaceutical Executive’ and ‘Life Science Leader’ Magazines (and other journals too!)